462 related articles for article (PubMed ID: 32308046)
21. Cerebroprotective action of angiotensin peptides in stroke.
Regenhardt RW; Bennion DM; Sumners C
Clin Sci (Lond); 2014 Feb; 126(3):195-205. PubMed ID: 24102099
[TBL] [Abstract][Full Text] [Related]
22. Interplay between the renin angiotensin system and oxidative stress contributes to alcohol addiction by stimulating dopamine accumulation in the mesolimbic pathway.
Sun M; Wu C; Liu L; Gu L; Wang Z; Xu F; Zhu D
Biochem Pharmacol; 2023 Jun; 212():115578. PubMed ID: 37137415
[TBL] [Abstract][Full Text] [Related]
23. [Renin-angiotensin-aldosterone system (RAAS) and its pharmacologic modulation].
Giestas A; Palma I; Ramos MH
Acta Med Port; 2010; 23(4):677-88. PubMed ID: 20687997
[TBL] [Abstract][Full Text] [Related]
24. Balancing Effect of Biejiajian Oral Liquid () on ACE-Ang II-AT1R Axis and ACE2-Ang-(1-7)-Mas Axis in Rats with CCl
Li XY; Peng Y; Bu XW; Yao J; Yao L
Chin J Integr Med; 2018 Nov; 24(11):853-859. PubMed ID: 29335866
[TBL] [Abstract][Full Text] [Related]
25. A New Perspective on the Renin-Angiotensin System.
Martyniak A; Tomasik PJ
Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611307
[TBL] [Abstract][Full Text] [Related]
26. Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.
Foureaux G; Nogueira JC; Nogueira BS; Fulgêncio GO; Menezes GB; Fernandes SO; Cardoso VN; Fernandes RS; Oliveira GP; Franca JR; Faraco AA; Raizada MK; Ferreira AJ
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4296-306. PubMed ID: 23702784
[TBL] [Abstract][Full Text] [Related]
27. Key developments in renin-angiotensin-aldosterone system inhibition.
Sevá Pessôa B; van der Lubbe N; Verdonk K; Roks AJ; Hoorn EJ; Danser AH
Nat Rev Nephrol; 2013 Jan; 9(1):26-36. PubMed ID: 23165302
[TBL] [Abstract][Full Text] [Related]
28. BML-111, a lipoxin receptor agonist, protects against acute injury via regulating the renin angiotensin-aldosterone system.
Chen QF; Hao H; Kuang XD; Hu QD; Huang YH; Zhou XY
Prostaglandins Other Lipid Mediat; 2019 Feb; 140():9-17. PubMed ID: 30412790
[TBL] [Abstract][Full Text] [Related]
29. New approaches to blockade of the renin-angiotensin-aldosterone system: overview of regulation of the renin-angiotensin-aldosterone system.
Nishiyama A; Kim-Mitsuyama S
J Pharmacol Sci; 2010; 113(4):289-91. PubMed ID: 20675960
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review.
Ferreira AJ; Bader M; Santos RA
Expert Opin Ther Pat; 2012 May; 22(5):567-74. PubMed ID: 22510001
[TBL] [Abstract][Full Text] [Related]
31. Recent Update of Renin-angiotensin-aldosterone System in the Pathogenesis of Hypertension.
Moon JY
Electrolyte Blood Press; 2013 Dec; 11(2):41-5. PubMed ID: 24627703
[TBL] [Abstract][Full Text] [Related]
32. Local ocular renin-angiotensin system - a target for glaucoma therapy?
Vaajanen A; Vapaatalo H
Basic Clin Pharmacol Toxicol; 2011 Oct; 109(4):217-24. PubMed ID: 21599836
[TBL] [Abstract][Full Text] [Related]
33. The renin-angiotensin system in central nervous system tumors and degenerative diseases.
Haron S; Kilmister EJ; Davis PF; Stylli SS; Mantamadiotis T; Kaye AH; Hall SR; Tan ST; Wickremesekera AC
Front Biosci (Landmark Ed); 2021 Sep; 26(9):628-642. PubMed ID: 34590472
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo.
Echeverría-Rodríguez O; Del Valle-Mondragón L; Hong E
Peptides; 2014 Jan; 51():26-30. PubMed ID: 24184594
[TBL] [Abstract][Full Text] [Related]
35. Emerging drugs which target the renin-angiotensin-aldosterone system.
Steckelings UM; Paulis L; Unger T; Bader M
Expert Opin Emerg Drugs; 2011 Dec; 16(4):619-30. PubMed ID: 21905943
[TBL] [Abstract][Full Text] [Related]
36. Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients.
Trošt Rupnik A; Pajek J; Guček A; Osredkar J; Kovač D; Bren A; Klančič D; Saksida S; Rus I; Globokar M; Drozg A; Lešnik M; Plešivčnik Z; Ekart R; Lopert S; Lindič J
Ther Apher Dial; 2013 Aug; 17(4):425-30. PubMed ID: 23931884
[TBL] [Abstract][Full Text] [Related]
37. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
Pernomian L; Pernomian L; Baraldi Araújo Restini C
Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
[TBL] [Abstract][Full Text] [Related]
38. [Effect of RAAS inhibition on stroke prevention].
Tanahashi N
Nihon Rinsho; 2012 Sep; 70(9):1582-7. PubMed ID: 23012807
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-(1-7): beyond the cardio-renal actions.
Passos-Silva DG; Verano-Braga T; Santos RA
Clin Sci (Lond); 2013 Apr; 124(7):443-56. PubMed ID: 23249272
[TBL] [Abstract][Full Text] [Related]
40. The function of the ACE2/Ang(1-7)/Mas receptor axis of the renin-angiotensin system in myocardial ischemia reperfusion injury.
Xie JX; Hu J; Cheng J; Liu C; Wei X
Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):1852-1859. PubMed ID: 35363333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
